Sabang, Caslyn Joy M.

HRN: 23-82-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2023
CEFUROXIME 1.5GM (VIAL)
09/30/2023
10/07/2023
IV
1.5g
Q8 X 7 Days
S/P LTCS
Waiting Final Action 
09/30/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/30/2023
10/07/2023
IV
500mg
Q8 X 7 Days
S/P LTCS
Waiting Final Action 
10/01/2023
CEFUROXIME 500MG (TAB)
10/01/2023
10/07/2023
PO
500mg
BID
S/p CS
Waiting Final Action 
10/01/2023
METRONIDAZOLE 500MG (TAB)
10/01/2023
10/07/2023
PO
500mg
TID
S/p CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: